STAT+: Kulkarni victorious in best biopharma CEO vote; Leschly tops worst list
The best and worst biopharma CEOs of 2020, selected by STAT+ readers, are Sam Kulkarni of CRISPR Therapeutics and Nick Leschly of Bluebird Bio.
This is one of the most fascinating paired selections in all the years that I’ve been naming best and worst biopharma CEOs.
Continue to STAT+ to read the full story…
